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Introduction
The promyelocytic leukemia (PML) protein and PML nuclear 
bodies (NBs) are implicated in several cellular processes, in-
cluding transcriptional regulation, tumor suppression, apopto-
sis, DNA repair, and the replication of both viral and cellular 
DNA (for reviews see Zhong et al., 2000; Everett, 2001; 
  Salomoni and Pandolfi  , 2002; Dellaire and Bazett-Jones, 2004). 
How they contribute to these nuclear activities, however, has re-
mained elusive. In normal mammalian cells, the PML protein 
coaccumulates in 5–30 NBs (Dellaire and Bazett-Jones, 2004) 
with as many as 75 other proteins (listed in the Nuclear Protein 
Database; Dellaire et al., 2003). Rather than just sequestering 
these proteins, there is compelling evidence that the bodies 
serve as sites for the posttranslational modifi  cation of nuclear 
proteins. For example, the coaccumulation of p53, CBP, and 
HIPK2 in PML NBs contributes to the regulated phosphoryla-
tion (by HIPK2) and acetylation (by CBP) of p53 in response to 
DNA damage (D’Orazi et al., 2002; Hofmann et al., 2002).
The structural and dynamic behavior of PML NBs is inti-
mately linked to the cell’s chromatin integrity (Eskiw et al., 
2004; Dellaire et al., 2006). Extensive chromatin contacts on 
the periphery of the protein cores of the NBs may account for 
their positional stability through extended periods in interphase 
of the cell cycle. Physical contacts with chromatin may be im-
portant for their proposed role in DNA replication. For example, 
early transcription and replication of the genomes of several 
DNA viruses occur immediately adjacent to PML NBs (Everett, 
2001). A link between PML NBs and chromatin is also demon-
strated in the maintenance of telomeres through a recombina-
tion mechanism called alternative lengthening of telomeres, 
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  T
he promyelocytic leukemia (PML) nuclear body 
(NB) is a dynamic subnuclear compartment that is 
implicated in tumor suppression, as well as in the 
transcription, replication, and repair of DNA. PML NB 
number can change during the cell cycle, increasing in 
S phase and in response to cellular stress, including DNA 
damage. Although topological changes in chromatin 
  after DNA damage may affect the integrity of PML NBs, 
the molecular or structural basis for an increase in PML 
NB number has not been elucidated. We demonstrate 
that after DNA double-strand break induction, the in-
crease in PML NB number is based on a biophysical pro-
cess, as well as ongoing cell cycle progression and DNA 
repair. PML NBs increase in number by a supramolecu-
lar ﬁ  ssion mechanism similar to that observed in S-phase 
cells, and which is delayed or inhibited by the loss of 
function of NBS1, ATM, Chk2, and ATR kinase.  Therefore, 
an increase in PML NB number is an intrinsic element 
of the cellular response to DNA damage.
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whereby a subset of PML NBs in late S/G2 phase become asso-
ciated with nascent DNA synthesis, DNA repair factors, and 
telomere proteins (Yeager et al., 1999; Grobelny et al., 2000). 
The connection between PML NBs and chromatin also extends 
to a possible role for PML NBs in DNA repair mechanisms. For 
example, after DNA damage, several DNA repair factors transit 
to and from PML NBs, and the bodies themselves have been re-
ported to colocalize with sites of unscheduled DNA synthesis in 
damaged cells (Dellaire and Bazett-Jones, 2004). PML may 
also function in DNA damage signaling because PML-null cells 
fail to fully activate p53 in response to DNA damage (Guo et al., 
2000) and the PML protein is phosphorylated in response 
to DNA double-strand breaks (DSBs) by Chk2 (Yang et al., 
2002) and ataxia telangiectasia and Rad3-related (ATR) kinase 
  (Bernardi et al., 2004). It is unclear whether these modifi  cations 
of PML or PML NB composition are critical for DNA repair to 
proceed or are a consequence of ongoing repair. Regardless, 
PML NBs are clearly more than passive accumulations of 
 nuclear  proteins.
We propose in this study that PML NBs can be used to 
monitor the topological state and integrity of chromatin in mam-
malian cells. In so doing, they act as sensors of DNA damage. 
Previously, we have shown that when the topological state of 
chromatin is altered during early S phase by the replication of 
DNA, PML NBs lose both radial symmetry and integrity, frag-
menting into “microbodies” by a fi  ssion mechanism (Dellaire 
et al., 2006). We demonstrate a similar response of PML NBs 
after the introduction of DNA DSBs, thereby providing a basis 
for previous observations of increases in PML NB number after 
DNA damage with ionizing radiation (IR; Carbone et al., 2002; 
Xu et al., 2003). We demonstrate that PML NB breakdown 
  occurs in two components. The fi  rst is a rapid biophysical 
  response, occurring in cells damaged at 4°C, a state in which 
ongoing DNA repair is inhibited, and a second component as-
sociated with repair mechanisms. Inactivation or loss of repair 
factors, such as Nbs1 or the checkpoint kinases ataxia telangiec-
tasia mutated (ATM), Chk2, and ATR, inhibits PML microbody 
formation in response to DSBs. We suggest that the PML NBs 
are highly sensitive DNA damage sensors whose dynamic be-
havior refl  ects both the degree of DNA damage and the integ-
rity of the DNA repair pathways involved in maintaining the 
mammalian genome.
Results
The increase in PML NB number 
in response to DSBs is sensitive, rapid, 
and dose dependent
The mechanism responsible for an increase in PML NBs after 
DNA damage (Carbone et al., 2002; Xu et al., 2003) has not 
been elucidated. To address specifi  cally how DSBs might con-
tribute to this process, we characterized the response of PML 
NBs to DSBs in the normal human diploid fi  broblast (NHDF) 
cell line GM05757 using IR, etoposide (VP16), and doxorubi-
cin (Fig. 1). IR generates both single-strand breaks and DSBs in 
DNA, whereas the topoisomerase II inhibitors VP16 and doxo-
rubicin primarily create DSBs (for review see Kurz and Lees-
Miller, 2004). PML NBs were counted in maximum-intensity Z 
projections of individual cells. In agreement with previous 
work, we found that PML NB number increased after DSB in-
duction (Fig. 1 A). Furthermore, we found that the time point 
associated with the highest number of PML NBs coincided with 
the peak of H2AX phosphorylation (γ-H2AX; Fig. 1 B), an 
event that occurs on chromatin surrounding DSBs (Rogakou 
et al., 1999). Maximum PML NB number correlated with peak 
γ-H2AX signal regardless of the method of DSB induction, 
suggesting that the increase in PML NB number is coupled 
to DSB formation. PML NB induction was most rapid for IR, 
peaking at 30 min after IR (Fig. 1, C and D). In contrast, 
γ-H2AX signal and PML NB number peaked later, 3 h after 
treatment with VP16 or doxorubicin (Fig. 1, B–D). Consistent 
with previous studies of PML NB association with γ-H2AX 
and components of the Mre11–Rad50–Nbs1 (MRN) complex 
(Carbone et al., 2002; Xu et al., 2003), we observed foci of 
γ-H2AX and Nbs1 that partially colocalized with or were 
  juxtaposed to PML NBs between 6 and 18 h after DSB induction 
(Fig. 1 B and Fig. S1 A, available at http://www.jcb.org/cgi/ 
content/full/jcb.200604009/DC1). In contrast, we observed a 
much earlier colocalization and juxtaposition between the foci 
of RPA and PML NBs at 1.5 h after DSB induction, which 
  persisted for up to 18 h (Fig. S1 B). After etoposide treatment, 
only a subpopulation of cells in S and G2 phase develop replica-
tion protein A (RPA) foci in NHDFs. Therefore, the association 
of PML NBs with RPA foci after DNA damage is restricted to 
S and G2 phase of the cell cycle (Fig. S1 C).
We then tested whether the increase in PML NB number 
in response to DSBs is dose dependent by treating cells with 
doses of IR varying from 0–10 grays (Gy; Fig. 1, E and F). We 
found that at doses as low as 1 Gy (i.e., producing  35 DSBs; 
Bristow and Hill, 2005), PML NBs increased in number in 
NHDFs, and the response was dose dependent, based on analysis 
of variance (ANOVA) between our datasets (Table S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200604009/DC1). 
In contrast to low doses of IR, where the number of PML NBs 
returned to baseline levels by 24 h after irradiation, at higher 
doses of 5 and 10 Gy, PML NB numbers remained elevated for 
an extended period of time (Fig. 1, E and F). Therefore, after 
low doses of IR, the increase in PML NB number after DNA 
damage appears to be reversible. When PML NB number is plot-
ted versus dose of IR, NB number appeared to reach a plateau at 
doses of 5 Gy or above for all time points, with the exception of 
24 h (Fig. 1 F). Therefore, PML NB number varies with the 
power of the dose of IR and can be described by the modifi  ed 
power function, y = a × b
X + c, where y is the number of PML 
NBs and x is the dose of IR in grays (Fig. S2 A). Thus, the in-
crease in PML NB number in response to DSBs is rapid, sensi-
tive to sublethal levels of DNA damage, and dose dependent.
PML protein and NB dynamics in response 
to DSBs
The dynamics of PML NBs after DSB induction with VP16 was 
examined by live cell analysis of U-2 OS cells stably expressing 
PML isoform IV (Fig. 2). We found that within 5 min after 
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began to appear adjacent to the larger PML NBs that were pres-
ent before treatment (Fig. 2 A). These new bodies, which we 
term microbodies, arise from preexisting PML NBs by a supra-
molecular fi  ssion mechanism, as confi  rmed by spinning-disc 
confocal microscopy (Fig. 2 B and Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200604009/DC1). This fi  ssion 
mechanism is similar to that observed for new PML NB forma-
tion in early S phase (Dellaire et al., 2006), as PML NB’s bio-
chemical composition was initially indistinguishable between 
microbodies and the larger parental PML NBs, in respect to Sp100 
and small ubiquitin-like modifi  er (SUMO-1) content (Fig. S3). 
However, although Sp100 levels at PML NBs did not change 
over the time course observed (Fig. S3 A), we did notice a 
  reproducible drop in SUMO-1 levels in PML NBs at 3 h after 
VP16 treatment (Fig. S3, B and C). Overexpression of SUMO-1 
dramatically reduced PML NB number (Fig. S3 D), resulting in 
enlarged bodies that showed reduced or delayed increase in 
PML NB number in response to DSBs (Fig. S3 E). It is unclear 
if overexpression of SUMO-1 is directly or indirectly responsi-
ble for the stabilization of PML NBs in our experiments be-
cause sumoylation is implicated in many biological pathways, 
including DNA repair (Gill, 2004).
Figure 1.  PML NB number increases in response to DSBs in NHDFs. NHDF cells (GM05757) were treated with varying doses of IR, etoposide (20 μM 
VP16), or 1.5 μM doxorubicin for 30 min to induce DSBs. (A) IF analysis of PML NB number in maximum-intensity Z projections of NHDFs after etoposide; 
time after treatment is indicated in hours. (B) IF analysis of the distribution of PML NBs in relation to DSBs in NHDFs after 2 Gy IR or VP16. γ-H2AX is used 
as a marker for chromatin containing DSBs, and asterisks mark the time points in which the maximum ﬂ  uorescence intensity of γ-H2AX was ﬁ  rst detected. 
Arrowheads indicate juxtaposition of γ-H2AX and PML NBs at 18 h after DNA damage (inset). Images represent a single focal plane. (C) Comparison of 
mean PML NB number over time after IR, VP16, and doxorubicin treatment. (D) Comparison of fold increase in PML NB number over time after IR, VP16, 
and doxorubicin treatment. (E and F) Response of PML NBs to graded doses of IR expressed as a function of time (E) or at each time point as a function of 
dose (F). Bars, 5 μm.JCB • VOLUME 175 • NUMBER 1 • 2006  58
  irradiated and fi  xed on ice to prevent diffusional movement of 
PML protein or ongoing DNA repair (Fig. 2 C). At temperatures 
<15°C, PML protein diffusion is very limited, as confi  rmed by 
FRAP analysis (Fig. 2 D). Interestingly, we also observed a 
10% difference in the maximum fl  uorescence recovery between 
control and etoposide-treated cells, consistent with a larger im-
mobile fraction of PML protein in bodies after DNA damage 
(Fig. 2 D).
We next examined the behavior of PML NBs in the vicin-
ity of site-specifi  c DSBs induced by UV laser irradiation (Fig. 3, 
A and B; and Video 2, available at http://www.jcb.org/cgi/ 
content/full/jcb.200604009/DC1). Within 5 min of the induc-
tion of DSBs, PML NBs in the vicinity of the laser track began 
to move and coalesce (Fig. 3 A, arrowheads). This process con-
tinued for over 20 min, resulting in a drop in PML NB number 
from 21 to 17 NBs, but did not affect PML NBs distal to the 
  laser track (Fig. 3 A). At later time points, however, even PML 
NBs far from the laser track lost their positional stability. 
  Imaging of cells in the absence of UV laser microbeam irradia-
tion did not affect the mobility or number of PML NBs (Video 3). 
Continuous imaging by laser scanning confocal microscopy 
(LSM) after DNA damage did not reveal microbody formation, 
likely because of photobleaching and the loss of visibility of 
small, PML-containing structures. However, after fi  xation and 
immunofl  uorescence (IF)  detection of PML and γ-H2AX by 
wide-fi  eld microscopy 1 h after photoinduction of DNA DSBs, 
it was apparent that the DNA damage was confi  ned to the laser 
track and that PML NB number had increased from 17 to 36 
PML NBs (Fig. 3 B).   Although wide-fi  eld microscopy is generally 
Figure 2.  PML protein and PML NB dynamics after DSB induction. (A) PML 
microbody formation occurs rapidly after treatment with etoposide. Two 
U-2 OS human osteosarcoma cells stably expressing GFP-PML IV protein 
were imaged by ﬂ  uorescence microscopy before (T = 0) and after addition 
of etoposide (20 μM VP16; T = 5 min and T = 2 h). Enlarged region of 
the cell marked by white asterisk is shown at each time point. White 
  arrowheads indicate newly formed microbodies after VP16 treatment. 
(B) Formation of PML microbodies in response to DNA DSBs occurs by su-
pramolecular ﬁ  ssion from preexisting parental PML NBs. A U-2 OS cell ex-
pressing GFP-PML IV was visualized before (T = 0) and during treatment 
with 20 μM VP16 over several minutes (T = 0.5, 1.0, and 1.5 min are 
shown). Arrowhead indicates ﬁ  ssion of a PML microbody from a larger pa-
rental PML NB. (C) PML NBs increase in number in cells irradiated on ice. 
NHDFs (GM05757s) were incubated on ice for 20 min and either ﬁ  xed 
(Control) or irradiated on ice (10 Gy IR) before ﬁ  xation. Mean PML NB 
number increases signiﬁ  cantly between control (17 ± 1; n = 30) and cells 
irradiated with 10 Gy IR on ice (24 ± 2; n = 30; *, P = 0.0008). (D) Dy-
namics of the PML protein within PML NBs is affected by DNA damage and 
reduced temperature. Asynchronous U-2 OS GFP-PML IV cells were sub-
jected to treatment with etoposide (20 μM VP16 for 30 min) before mobil-
ity of PML protein within PML NBs was analyzed by FRAP at 37°C (n = 20). 
Mobility of the PML protein at PML NBs in DNA damaged cells is com-
pared with control untreated cells (n = 20) at 37°C and at 15°C (n = 7). 
Data are presented as the mean ﬂ  uorescence recovery plotted as percent 
of initial ﬂ  uorescence intensity of the PML NB over 14 min. Error bars rep-
resent the standard error. Bars, 5 μm.
Figure 3.  PML NBs lose positional stability when chromatin is damaged 
in their vicinity. (A) UV laser–induced DSBs alter the positional stability of 
PML NBs. A single U-2 OS cell expressing GFP-PML IV is shown, in which 
DSBs were created in a laser track along a deﬁ  ned ROI ( 0.5 × 10 μm; 
rectangular box) by photoinduction; PML NB movement was tracked over 
time. PML NBs (arrowheads) along the laser path (rectangular box) move 
toward and aggregate with one large PML NB (arrow) adjacent to the 
laser track. PML NB number (NB#) is shown before laser induction of 
DSBs and 22 min after induction. (B) Conﬁ  rmation of laser-induced DSBs 
by IF detection of γ-H2AX. The same cell shown in A was ﬁ  xed at 60 min 
after laser induction of DSBs and processed for immunodetection of 
PML and γ-H2AX. PML NB number at this time point is indicated (NB#). 
Bars, 5 μm.
PML microbodies also formed immediately after irradia-
tion with doses as low as 1 Gy of IR (unpublished data), and an 
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more sensitive than LSM in the detection of PML microbodies, 
we found that LSM was suffi  cient to detect >90% of bodies 
within a focal plane (unpublished data). Therefore, the increase 
in the number of PML NBs at 1 h after DSB induction is 
  primarily caused by microbody formation.
Structural destabilization of PML NBs 
correlates closely with topological changes 
in chromatin after DNA damage
To address the ultrastructural changes in PML NBs after DNA 
damage, we used immunogold detection of PML with correla-
tive light microscopy (LM) and electron spectroscopic imaging 
(ESI; Dellaire et al., 2004; Fig. 4). Using LM/ESI we observed 
that, in control NHDFs, PML NBs exhibit radial symmetry and 
make extensive contacts with the surrounding chromatin (Fig. 4 A). 
Upon treatment with VP16, we found that PML NBs lose 
their radial symmetry and make fewer contacts with the sur-
rounding chromatin fi  bers. We also observed “microbody-like” 
structures, which were identifi  ed by immunogold detection of 
PML, adjacent to chromatin in the vicinity of larger “parental” 
PML NBs (Fig. 4, B and C). A much larger interchromatin do-
main space was also apparent in cells treated with VP16 (black 
spaces outside of chromatin in Fig. 4). These changes in both 
chromatin and PML NBs are reminiscent of those seen in cells 
entering S phase (Dellaire et al., 2006). Based on these results, 
we suggest that the introduction of DSBs results in topological 
changes in chromatin linked to PML NBs, which destabilizes 
the PML NB core.
The increase in PML NB number 
in response to DSBs does not require 
p53 or ongoing protein translation
PML protein levels can increase after treatment with IR in a 
p53-dependent manner (de Stanchina et al., 2004). Therefore, 
we examined the PML NB response to DNA DSBs in NHDFs 
with inhibition of PML protein synthesis by treatment with 
  cycloheximide, and in cells that lack a functional p53 pathway 
(i.e., null p53 human Saos-2 osteosarcoma cells and paired 
HCT116 cell lines, which were isogenic save for p53 protein; 
Fig. 5). We found that PML protein levels increased slightly, by 
1.3-fold at 4 h after VP16 treatment, and that they reached 1.8-
fold by 12 h (Fig. 5 A). As expected, cycloheximide treatment 
inhibited the DNA damage–dependent increase in PML protein 
levels at 12 h, but had little effect at 4 h, suggesting that post-
translational regulation of PML protein levels may occur at this 
earlier time point. We found that inhibition of protein synthesis 
or loss of p53 function did not prevent the initial increase in 
PML NB number (at 30 min and 3 h) in response to DSBs 
(Fig. 5, B–C). Loss of p53 in the HCT116 cell background 
  actually appeared to enhance the increase in PML NB numbers at 
30 min after VP16 treatment (Fig. 5 C),  perhaps because further 
genome instability from a concurrent loss of the mismatch 
  repair factor MLH1 (Koi et al., 1994).
Cycloheximide-treated NHDFs exhibited a higher num-
ber of PML NBs initially, compared with untreated cells, and 
NB number returned to control levels much earlier than in 
  untreated NHDFs (Fig. 5 B). In contrast, PML NB number in 
Figure 4.  Ultrastructural analysis of PML NBs in NHDFs by correlative 
LM/ESI before and after etoposide-induced DNA damage. Regions of inter-
est containing a PML NB, which are shown at higher magniﬁ  cation in sub-
sequent images, are delineated by white boxes. (A) LM/ESI of a single 
NHDF (GM05757) cell, ﬂ  uorescently labeled for PML protein. Elemental 
maps of nitrogen (N) and phosphorus (P), and the merged maps of a PML 
NB and its surrounding nucleoplasm reveal protein-based (cyan) and nu-
cleic acid-based (yellow) components. Chromatin appears yellow in the 
merged image because of high N and P content. A single PML NB is 
shown at higher magniﬁ  cation (cyan, as indicated by the arrow) making 
many contacts to the surrounding chromatin (yellow), and has radial sym-
metry typical of PML NBs in unstressed cells. (B) LM/ESI of a single NHDF 
(GM05757) treated with 20 μM etoposide (VP16) for 30 min, ﬂ  uores-
cently labeled for PML protein. After treatment with VP16, the protein core 
of PML NB is disrupted in response to DSB induction; few contacts with 
chromatin remain, and radial symmetry is lost. (C) PML NB in B, at higher 
magniﬁ  cation (left), and a cartoon representation of the same EM micro-
graph (right), where PML protein–containing protein structures (red), chro-
matin (yellow), and other nonchromosomal protein (blue) are shown. 
Redistribution of PML microbodies along chromatin ﬁ  bers (asterisks) is ob-
served, and larger interchromatin spaces (black areas) are apparent. PML 
protein localization was determined by immunogold detection of PML 
(white dots). Bars, 500 nm.JCB • VOLUME 175 • NUMBER 1 • 2006  60
VP16-treated Saos-2 cells continued to increase over time (Fig. 
5 B). PML NB number is affected by cell cycle progression and 
increases in early S phase (Dellaire et al., 2006). FACS analysis 
revealed that after VP16 treatment, NHDFs showed a marked 
accumulation in G1 and G2 phase of the cell cycle by 18 h 
(Fig. S4 A, available at http://www.jcb.org/cgi/content/full/
jcb.200604009/DC1). Therefore, differences in the number of 
cells in S phase at the late time points (6 and 18 h) might ac-
count for the continued increase in PML NBs observed in the 
G1/S checkpoint-defi  cient Saos-2 cells. We examined this pos-
sibility by detecting BrdU incorporation at 18 h after VP16 
treatment to determine the fraction of cells replicating DNA 
(Fig. 5 D). We estimate that  40% of the Saos-2 cells were in 
S phase, compared with only 5–6% of NHDFs, and no BrdU in-
corporation was observed in NHDFs treated with  cycloheximide. 
Therefore, at early time points, the increase in PML NB number 
is independent of both new protein synthesis and p53. However, 
at later time points after DNA damage, PML NB number is 
  sensitive to loss of p53 caused by abrogation of the G1/S check-
point, and as a result, PML NB number continues to increase as 
cells enter S phase inappropriately.
The increase in PML NB number in 
response to DSBs is abrogated by caffeine 
and inhibited by the loss of function 
of Nbs1, ATM, Chk2, and ATR kinase
Because ATM, ATR, and Chk2 kinase are key regulators of the 
cellular response to DNA damage (Shiloh, 2001; Pommier et al., 
2005), we examined whether chemical inhibition of these 
  kinases might affect the response of PML NB to DSBs in 
NHDFs (Fig. 6 A). Inhibition of ATR and ATM kinase by 5 mM 
caffeine had an inhibitory effect on the increase of PML NB 
number after VP16 treatment at all time points (P < 0.0001; 
Fig. 6 A). Similarly, caffeine signifi  cantly reduced the response 
of PML NBs to 5 Gy of IR (P < 0.001; Fig. S4 B). This effect 
was not caused by caffeine-dependent changes in the cell cycle 
profi  le because PML NB number did not change when cells 
were pretreated with caffeine for 30 min before induction of 
DSBs (Fig. 6 A), and only prolonged treatment with caffeine 
had an effect on the cell cycle profi  le of NHDFs, with or with-
out VP16 treatment (Fig. S4, A and C, 18 h). Pretreatment of 
NHDFs with the Chk2 kinase inhibitor II (Arienti et al., 2005) 
did not affect the initial increase in PML NBs in response 
to VP16, but did signifi  cantly reduce the number at 3 h, com-
pared with cells treated with VP16 in the absence of inhibitor 
(P < 0.0003; Fig. 6 A). Similarly, 20 μM wortmannin, which 
strongly inhibits DNA-PK and ATM kinase, but weakly inhibits 
ATR, had a signifi  cant effect on PML NB number only at 3 h 
after VP16 treatment (P < 0.001; Fig. 6 A). In contrast, the 
DNA-PK inhibitor LY2942002 had little effect on PML NB 
number in   response to DSBs.
Figure 5.  The increase in PML NB number in response to DSBs is inde-
pendent of new protein translation and p53. NHDF cells (GM05757) 
in the presence or absence of 150 μM cycloheximide (CHX), Saos-2 
  human osteosarcoma cells, and isogenic HCT116 human colon carcinoma 
cells (+ or − p53) were treated with etoposide (20 μM VP16) for 30 min 
(*, P < 0.0001). (A) Western blot analysis of PML protein levels after 
etoposide treatment in the presence or absence of cycloheximide. NHDFs 
were treated with etoposide (20 μM VP16 for 30 min) and harvested at the 
indicated times for SDS-PAGE and Western blot analysis. Ratio of PML pro-
tein levels in the control lane to PML protein at the indicated time points af-
ter etoposide treatment are shown normalized against actin. (B) Comparison 
of mean PML NB number after VP16 treatment in NHDFs, NHDFs treated 
with cycloheximide (+CHX), and Saos-2 cells. (C) Comparison of mean 
PML NB number after VP16 treatment in isogenic HCT116 and HCT116 
p53-null cells. (D) Comparison of DNA synthesis activity of NHDFs, NHDFs 
treated with cycloheximide (+CHX), and Saos-2 cells at 18 h after VP16 
treatment. 18 h after VP16treatment, cells were incubated with BrdU, ﬁ  xed, 
and processed for immunodetection of BrdU, and DNA was counterstained 
with DAPI. Asterisks represent BrdU-positive cells. Bars, 5 μm.PML NUCLEAR BODIES ARE DNA DAMAGE SENSORS • DELLAIRE ET AL. 61
We also treated several repair-defi  cient cell lines with 
VP16 to compare the PML NB response after DNA damage. 
As with chemical inhibition of ATM, AT cells, which are 
 defi  cient in ATM, showed a signifi  cant inhibition of PML NB 
number increase only at 3 h after VP16 treatment (P < 0.02; 
Fig. 6 B), after which PML NB number actually increased 
  beyond that expected for NHDFs at 6 h. AT-like disorder 
(ATLD) cells expressing mutant Mre11 (Stewart et al., 1999), 
which is a component of the DNA damage sensor known as the 
MRN complex (D’Amours and Jackson, 2002), showed an 
  initial increase in PML NB number after VP16 treatment at 
30 min, which is similar to NHDFs. At the 3-h time point 
and thereafter, however, the increase in PML NB number was 
  inhibited by loss of Mre11 function (P < 0.0001; Fig. 6 B). 
The increase in PML NB number after induction of DSBs was 
signifi  cantly inhibited at all time points observed in Nijmegen 
breakage syndrome (NBS) cells, which are defi  cient in Nbs1, 
which is also a member of the MRN complex (Carney et al., 
1998), and was profoundly inhibited in Seckel syndrome cells, 
which are defi  cient in ATR kinase (P < 0.0001; Fig. 6 B; 
O’Driscoll et al., 2003).
Because the concentration of Chk2 inhibitor used in our 
experiments could have residual effects on other kinases (<25% 
inhibition of a panel of 35 kinases, Arienti et al., 2005), we 
wished to confi  rm the role of Chk2 in regulating the response of 
PML NBs to DSBs using a genetic mouse model. As predicted 
from our inhibitor data, Chk2 −/− murine embryonic fi  broblasts 
(MEFs) had an abrogated PML NB response to DSBs, compared 
with isogenic wild-type MEFs at 3 h after VP16 treatment 
(P < 0.001; Fig. 7 A). Similarly, reconstitution of NBS cells 
with wild-type human Nbs1 by retroviral transduction resulted 
in a robust increase in NB number at 3 h after VP16 treatment, 
confi  rming a role for Nbs1 in regulating the PML NB response 
to DSBs (P < 0.02; Fig. 7 B). Finally, we further characterized 
the role of ATR kinase in regulating the response of PML NBs 
to DSBs by VP16 treatment of U-2 OS cells expressing an 
  inducible dominant-negative mutant of ATR (kinase-dead   
ATR-DN; Fig. 7 C; Nghiem et al., 2001). Induction of ATR-DN 
in these U-2 OS cells for 24 h before VP16 treatment signifi  -
cantly inhibited PML NB induction at 30 min, 3 h (P < 0.0001), 
and 6 h after treatment (P < 0.001; Fig. 7 C). Interestingly, 
PML NB numbers continued to rise in U-2 OS cells expressing 
the ATR-DN protein, possibly because of extensive genome 
  instability and eventual apoptosis associated with prolonged ex-
pression of this protein. Even within the population of U-2 OS 
cells expressing the ATR-DN protein, high expression corre-
lated with reduced PML NB number, compared with low-
  expressing cells at 3 h after VP16 treatment (Fig. 7 C).
Discussion
PML NBs make extensive contacts to chromatin in their vicin-
ity, which accounts both for their positional stability during in-
terphase (Eskiw et al., 2004) and their highly dynamic behavior 
in S phase, when chromatin topology is altered during DNA 
replication (Dellaire et al., 2006). Because of their intimate 
  relationship with chromatin, we previously hypothesized that 
PML NBs might also represent sensors of DNA damage (Dellaire 
and Bazett-Jones, 2004). In this study, we have systematically 
tested this hypothesis, demonstrating that PML NBs behave as 
dose-dependent sensors of DSBs.
PML NBs initially respond to DSBs 
by increasing in number by ﬁ  ssion
Chromatin is physically constrained by subnuclear compart-
ments such as the nucleolus and the nuclear lamina (Chubb 
et al., 2002). Chromatin contacts on the surfaces of the protein-
based cores of PML NBs may also serve as chromatin- anchoring 
sites (Fig. 8 A). The positional stability of PML NBs and the 
low rates of chromatin mobility indicate a balance of forces be-
tween chromatin and such anchoring sites. Recently, we have 
shown that chromatin appears to “relax,” or decondense, in the 
vicinity of DSBs (Kruhlak et al., 2006). This balance of forces, 
or tensegrity, may be altered by the introduction of DSBs in 
chromatin, and could lead to the shearing of the PML NB core 
as the associated chromatin domains pull away from the body. 
One outcome of this biophysical response is the supramolecular 
fi  ssion of PML NBs into microbodies immediately after the 
Figure 6.  The increase in PML NB number in response to DSBs is delayed 
or inhibited in the presence of PI3 kinase inhibitors and in DNA repair–
  deﬁ  cient cell lines. (A) Comparison of effects of DNA repair kinase inhibitors 
on the increase in PML NB number in response to DSBs. NHDF cell line 
GM05757 (control) was pretreated with 10 μM Chk2 kinase inhibitor 
(Chk2 inhibitor II) or various PI3 kinase inhibitors (5 mM caffeine, 20 μM 
wortmannin, or 50 μM LY2942002) for 30 min before treatment with 
etoposide (20 μM VP16 for 30 min; *, P < 0.0001; **, P < 0.001). 
(B) Comparison of the fold increase in PML NB number after etoposide 
treatment (20 μM VP16 for 30 min) in NHDF cells and DNA repair–
  deﬁ  cient human ﬁ  broblast cell lines. AT, ataxia telangiectasia; NBS, Nijmegan 
breakage syndrome; ATLD, AT-like disorder; Seckel, Seckel syndrome. 
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  introduction of DSBs (Fig. 8 B). We propose that the biophysical 
response to changes in chromatin tensegrity is the primary basis 
for the fi  ssion of PML NBs when cells are irradiated at 4°C 
(Fig. 2 C), a condition under which biochemical activities, such 
as DNA repair and biochemical changes to chromatin and PML 
NBs, are almost entirely blocked (Fig. 8 B). It is unlikely that 
de novo formation of PML NBs (Everett and Murray, 2005) by 
the redistribution of PML protein accounts for the initial  increase 
in the number of PML NBs because protein diffusion is very 
limited below 15°C (Fig. 2 D). Furthermore, an ultrastructural 
examination of PML NBs in situ after DSB induction with 
VP16 revealed that the protein core of the PML NB is indeed 
destabilized in conjunction with structural changes in  chromatin 
(Fig. 4 B). A similar instability of PML NB structure is  observed 
Figure 7.  PML NB induction in response to DSBs requires NBS1, Chk2, and ATR-function. Cells were treated with etoposide (20 μM VP16 for 30 min), left 
to recover for 3 h, and processed for IF detection of PML. DNA was counterstained with DAPI. PML NB number is indicated in maximum-intensity Z projec-
tions of IF images of control and etoposide-treated cells (left) and a comparison of mean PML NB number (right) is shown. Error bars represent the SEM. 
Bars, 5 μm. (A) Comparison of the PML NB number between etoposide-treated Chk2-null (Chk2 −/−) and wild-type Chk2 (Chk2 WT) MEFs (*, P < 0.001). 
(B) Comparison of PML NB number between Tert-immortalized human NBS ﬁ  broblasts infected with an empty retroviral vector (NBST pBabe) or a retroviral 
vector carrying wild-type human NBS1 (*, P < 0.02). (C) Disruption of ATR kinase function inhibits the increase in PML NB number in response to DSBs. U-2 
OS cells expressing a doxycycline-inducible, kinase-inactive, dominant-negative ATR kinase (ATR-DN) were treated with (+ Dox) or without doxycycline for 
24 h before etoposide treatment. Besides PML, IF detection of ATR-DN (Fl-ATR-DN) is also shown. Cells with high ATR-DN expression (arrow) contain fewer 
PML NBs after etoposide treatment than cells with low expression (arrowhead). White asterisks indicate two cells with similar PML NB number in cells not 
expressing ATR-DN. DNA was counterstained with DAPI. *, P < 0.0001; **, P < 0.001.PML NUCLEAR BODIES ARE DNA DAMAGE SENSORS • DELLAIRE ET AL. 63
in early S phase, where the NBs also break apart by fi  ssion 
  (Dellaire et al., 2006).
PML NBs are sensitive detectors 
of DNA damage
PML NBs behave as DNA damage sensors by increasing in 
number in response to genotoxic stress. The initial formation of 
microbodies by a fi  ssion mechanism is sensitive to as few as 35 
DSBs (1 Gy IR). However, PML NB number does not increase 
in a linear fashion with the dose of IR, in contrast to the induc-
tion of DSBs and, consequently, the phosphorylation of H2AX 
(Rogakou et al., 1999). At high doses of IR (>5 Gy), PML NB 
number per cell becomes saturated (Fig. 1 F). We can model the 
relationship of PML NB number to DSBs as a modifi  ed power 
function, where NB number varies with the power of the dose 
(Fig. S2 A). This relationship holds for PML NB number up to 
6 h after irradiation. In addition, at low doses of IR, PML NB 
number returns to control levels within 24 h, whereas at high 
doses of IR (i.e., 5 and 10 Gy), PML NB number remains 
  elevated. Doses of IR at 5 and 10 Gy are considered supralethal, 
as they inhibit cell growth in clonogenic assays by 90–100% 
(Bristow and Hill, 2005). Therefore, the failure of PML NB 
number to return to that of control cells after irradiation may be 
an indication of either eventual senescence or programmed cell 
death. PML NB number also remains elevated for extended 
  periods after DNA damage in cells that have impaired cell cycle 
checkpoints (e.g., caused by loss of p53; Fig. 5). Thus, at nonlethal 
physiological levels of DNA damage, PML NB number may 
provide a simple indicator of the complex response of mamma-
lian cells to DNA damage and the fi  delity of the p53-dependent 
G1/S checkpoint.
Live cell analysis demonstrates 
that PML NBs are not recruited 
to sites of DNA damage
PML NBs appear to associate with single-stranded regions of 
DNA, as well as with foci containing γ-H2AX and/or repair 
proteins after DNA damage (Dellaire and Bazett-Jones, 2004). 
We also observed the juxtaposition of γ-H2AX foci (Fig. 1 B) 
and the colocalization of Nbs1 with PML NBs at 6 and 18 h 
  after the induction of DSBs (Fig. S2 A). At 1.5 h after DSB 
  induction, we also observed the colocalization and juxtaposition 
of RPA foci with PML NBs in NHDFs in S and G2 phase of the 
cell cycle (Fig. S2, B–C). These data raise the possibility that 
PML NBs and DNA repair proteins may be able to coaccumu-
late at sites of DNA damage by the movement of intact PML 
NBs or by their de novo formation. We tested these assump-
tions by UV laser induction of DSBs in defi  ned regions of the 
nucleus of U-2 OS cells expressing GFP-PML IV (Fig. 3, A–B). 
PML NBs in close proximity to the laser-induced DSBs 
began to lose positional stability and NB number dropped as 
these “liberated” bodies aggregated with each other. However, 
we did not see the de novo formation of PML NBs along the 
length of the laser track, as would be expected if PML were 
coaccumulating at sites of DNA damage. Thus, although PML 
NBs lose positional stability when chromatin is damaged in 
their vicinity, they do not form de novo or move to sites of 
DNA damage. Rather, they are able to move large distances 
through the nucleoplasm, possibly through spaces or channels 
created in chromatin by the extensive number of DSBs created 
along the laser track   (Bradshaw et al., 2005). Such long-
range movement of PML NBs is consistent with “corral” models 
of NB movement within the interchromatin domain space 
Figure 8.  Summary of the biophysical and molecular 
mechanisms responsible for the increase in PML NB 
number in response to DSBs. (A) Model of the biophysical 
effect on PML NBs by changes in chromatin structure or 
tensegrity. Chromatin is constrained and under tension 
(double-headed arrows) by tethering to subnuclear com-
partments such as the nucleolus, nuclear lamina, and, 
  possibly, PML NBs. DSB-induced changes in chromatin 
structure or tensegrity alter the balance of forces constrain-
ing chromatin within the nucleus; this biophysical phenom-
enon destabilizes PML NBs that are tethered to chromatin, 
resulting in microbody formation by ﬁ  ssion from preexist-
ing NBs. (B) Model for PML NB number increase in re-
sponse to DSBs. Initially, PML NB number increases 
because of biophysical changes in chromatin after DSBs, 
as in A. The second phase of the PML NB response to 
DNA damage requires ongoing DNA repair processes, 
which can be inhibited by low temperatures (4°C) by inhi-
bition (caffeine) or loss of ATR kinase function (∆ATR) and, 
to a lesser extent, by loss of function of NBS1 (∆NBS1) or 
Chk2 (∆Chk2), whose activation is affected by inhibition 
of ATM (wortmannin). (C) Summary of DNA repair kinase 
pathways implicated in phosphorylation of the PML pro-
tein in response to DNA DSBs. It is currently unknown if 
ATM can directly phosphorylate PML.JCB • VOLUME 175 • NUMBER 1 • 2006  64
  (Eskiw et al., 2003; Gorisch et al., 2004). Eventually, PML 
NBs far from the laser track respond by changes in their movement 
and microbody formation, suggesting that either global changes 
in chromatin structure are occurring at later time points after 
DNA damage and/or ongoing DNA repair processes are re-
quired for this phenomenon. The colocalization of PML NBs 
with RPA in G2- and S-phase cells at 1.5 h after DSB induction 
may indicate a role for PML in homologous recombination 
events, such as sister-chromatin exchange, in cooperation with 
other factors, such as BLM (Hu et al., 2001; Rao et al., 2005). 
The signifi  cance of the colocalization and juxtaposition of NBs 
with γ-H2AX and Nbs1 at late time points after DNA damage 
(i.e., 6 and 18 h; Fig. S1 A) remains unclear because >90% of 
DNA repair has already been completed. Perhaps at these late 
time points, PML NBs may function as sites of posttransla-
tional modifi  cation of DNA repair factors at the end of the re-
pair cycle, rather than playing a direct role in the DNA repair 
mechanisms themselves.
Signaling pathways regulating DNA repair 
and PML NB response to DSBs share 
common factors
After the initial rapid formation of PML microbodies by a fi  ssion 
mechanism, further increases in PML NB number accom  pany 
ongoing DNA repair. This can be explained by the sensitivity 
of PML NBs to the topological state of chromatin (Dellaire 
et al., 2006), which is affected by chromatin remodeling associ-
ated with DNA repair (Lydall and Whitehall, 2005). Therefore, 
mutations in components of the DNA repair response could 
also abrogate the breakdown of PML NBs into microbodies. 
ATM and ATR kinases are key regulators of the cellular re-
sponse to DNA damage, which may play partially redundant 
roles because they share many of the same substrates, such as 
Chk2, Brca1, and p53 (for reviews see Shiloh, 2001; Pommier 
et al., 2005).
We addressed the role of the ATM and ATR DNA repair 
pathways in regulating the increase in PML NB number in re-
sponse to DSBs, by using both repair-defi  cient cell lines and 
chemical inhibition of ATM, ATR, and Chk2 kinase. AT cells 
expressing mutant ATM or NHDF treated with wortmannin, 
which is an inhibitor of ATM, demonstrated a similar delay in 
the increase in PML NBs in response to DSBs, which was most 
signifi  cant at 3 h after VP16 treatment (Fig. 6 A–B). A similar 
delay in the increase in PML NB number occurred at 3 h in 
NHDFs treated with a Chk2-specifi  c kinase inhibitor (Fig. 6 A) 
and in Chk2 −/− MEFs (Fig. 7 A). We also found that loss of 
Nbs1, which is a member of the MRN DNA   damage–sensing 
complex (D’Amours and Jackson, 2002) and is required for 
activation of Chk2 by ATM in response to low levels of DNA 
damage (Buscemi et al., 2001), caused a   signifi  cant delay in 
the increase in PML NB number in response to VP16 (Fig. 
6 B and Fig. 7 B). Therefore, the inhibition of PML microbody 
formation in NBS or AT cells at 3 h after etoposide treatment 
(Fig. 6 B) may result, in part, from a failure to activate Chk2 
in response to DSBs. In addition, chromatin topology changes 
after DNA damage may be subject to regulation by ATM 
kinase (unpublished data; Shiloh, Y., personal communication). 
Therefore, ATM’s role in regulating PML NB behavior after 
DNA damage could be twofold, (a) through the activation 
of Chk2 and (b) via modulation of chromatin topology after 
DNA damage.
NBS cells also initially had many fewer PML NBs at 
30 min after VP16 treatment compared with ATM- or Chk2-
 defi  cient cells. In contrast, Mre11-defi  cient ATLD cells showed an 
initial increase in PML NB number similar to NHDFs, followed 
by a signifi  cant reduction in PML NB number at all other time 
points. Because Nbs1 and Mre11 are in the same DNA damage–
sensing complex, the basis for this discrepancy between NBS 
and ATLD cells in regard to PML NB induction is unclear. 
An intriguing possibility is that Nbs1 may play an earlier and 
separate role in regulating the increase in PML NB number in 
response to DSBs beyond the activation of Chk2.
PML NB number after VP16 treatment was inhibited to 
an even greater extent in Seckel syndrome cells defi  cient in 
ATR (O’Driscoll et al., 2003) than for cells defi  cient in ATM, 
Chk2, or Nbs1 (Fig. 6 B). In addition, the dominant-negative 
inhibition of ATR kinase by expression of a kinase-dead mu-
tant of ATR (ATR-DN; Fig. 7 C) in U-2 OS cells also inhibited 
the increase in PML NB number in response to DSBs. The 
most dramatic inhibition, however, occurred when we inhib-
ited both ATM and ATR with caffeine (Fig. 6 A). At all time 
points after DSB induction, PML NB number remained at or 
below that of untreated cells. The additive effect of inhibi-
tion of ATM- and ATR-dependent pathways on the increase 
in PML NB number in response to DSBs by caffeine suggests 
they act in parallel pathways, which is consistent with their re-
dundant roles in regulating DNA damage checkpoints   (Shiloh, 
2001). Although the initial biophysical response of PML NBs 
is dependent on changes in the tensegrity and topological 
state of chromatin associated with DSB induction and DNA 
repair, it remains an intriguing possibility that ATR- or Chk2-
  dependent phosphorylation of PML and PML NB constituents 
(Yang et al., 2002; Bernardi et al., 2004) may also contribute 
to NB instability (Fig. 8 C). Other forms of DNA damage, 
such as UV irradiation (Seker et al., 2003), also appear to 
destabilize PML NBs. Because ATR kinase is strongly activated 
by UV irradiation, DNA single-strand breaks, and drugs that 
induce replication fork stalling (Shiloh, 2001), it is likely that 
the increase in PML NB number seen in response to these 
  cellular stresses is also regulated by ATR kinase. We are cur-
rently testing this hypothesis.
In summary, we have demonstrated that PML NBs are, 
indeed, dynamic sensors of DNA damage that respond to 
DNA DSBs by increasing in number, primarily by a fi  ssion 
  mechanism. The DSB-dependent increase in PML NBs occurs 
fi  rst as a biophysical response to changes in chromatin. However, 
soon after DSB induction, PML NB number becomes   sensitive 
to cell cycle checkpoint control and ongoing DNA repair, 
  being regulated by ATR kinase and, to a lesser extent, ATM 
kinase, possibly through Nbs1-dependent activation of Chk2 
kinase. This dynamic behavior of PML NBs in mammalian 
cells provides an exceptional pathological marker for cellular 
health, cell cycle progression, and the integrity and stability of 
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Materials and methods
Cell culture and drug treatments
Cell lines used in this study are as follows: NHDFs (GM05757; Coriell Cell 
Repository); human AT ﬁ  broblasts (AT5B1 and GM05823; Coriell Cell Re-
pository); human NBST ﬁ  broblasts (gift from J. Lukas, Danish Cancer Society, 
Copenhagen, Denmark); human ATLD ﬁ  broblasts (gift from Y. Shiloh, 
Tel Aviv University, Tel Aviv, Israel); Saos-2 (American Type Culture Collec-
tion [ATCC]); HCT116 and p53-null HCT116 isogenic cells (gift from 
B. Vogelstein, Johns Hopkins University, Baltimore, MD); ATR-DN and ATR-WT 
cells (gift from Paul Nghiem, University of Washington Medical School, 
  Seattle, WA); Seckel syndrome cells (GM18366; Coriell Cell Repository); 
Chk2 −/− MEFs and isogenic WT MEFs (gift from T. Mak, University of 
Toronto, Toronto, Canada); and isogenic and U2OS cells stably expressing 
GFP-PML IV (gift from J. Taylor, University of Wisconsin, Milwaukee, WI). 
NBST-pBabe and NBST-pBabe-NBS1 cell lines were generated by retrovi-
ral transduction of NBST ﬁ  broblasts using either pBabe-Puro alone or en-
coding full-length human Nbs1 (gift from J. Lukas), respectively. To generate 
DSBs, cells were treated with 20 μM etoposide (VP16; Sigma-Aldrich) or 
1.5 μM doxorubicin (Sigma-Aldrich) for 30 min, washed two times in PBS 
(WISENT, Inc.), and left to recover for the indicated time. We determined 
that 20 μM VP16 for 30 min was equivalent to  2 Gy of IR by the neutral 
comet assay (Fig. S2 B). Alternately, asynchronous cell cultures were ex-
posed to whole-cell IR (dose range, 0–20 Gy) using a 
137Cs irradiator 
(MDS Nordion) at 1 Gy/min (on ice, aerobic conditions). For kinase inhibi-
tion studies, cells were incubated with growth medium supplemented with 
20 μM wortmannin (Sigma-Aldrich), 5 mM caffeine (Sigma-Aldrich), 50 μM 
LY294002, or 10 μM Chk2 inhibitor II (EMD Biosciences, Inc.; Arienti 
et al., 2005) for 30 min, before addition of VP16 or exposure to IR. Cells 
were maintained in growth medium containing kinase inhibitors for the in-
dicated time. For the inhibition of protein synthesis, cells were treated with 
150 μg/ml of cycloheximide (Sigma-Aldrich) for 30 min before treatments 
and maintained in cycloheximide until processed for LM.
IF detection of proteins, live-cell imaging, and FRAP
Cells grown on coverslips were treated with or without kinase or protein 
synthesis inhibitors before DSB induction (etoposide or IR), ﬁ  xed, and pro-
cessed for IF as previously described (Dellaire et al., 2006). Primary anti-
bodies used in this study are as follows: rabbit anti-PML (CHEMICON 
International, Inc.); rabbit anti-Sp100 (CHEMICON International, Inc.); 
mouse anti-RPA (RPA34-20; Calbiochem); mouse anti–phospho-Histone H3 
(ser10; clone MC463; Millipore); rabbit anti–cyclin A (sc-751; Santa Cruz 
Biotechnology, Inc.); mouse anti–SUMO-1 (GMP-1; Invitrogen); mouse 
anti–γ-H2AX (JBW301; Millipore). Secondary antibodies conjugated to 
Cy3 and Cy5 were obtained from Jackson ImmunoResearch Laboratories, 
and secondary antibodies conjugated to Alexa Fluor 488 were obtained 
from Invitrogen. DNA was stained with DAPI (Sigma-Aldrich) in mounting 
media containing 90% glycerol and 1 mg/ml paraphenylenediamine 
(Sigma-Aldrich). Fluorescence micrographs of ﬁ  xed cells were collected us-
ing a 63×, 1.32 NA, oil-immersion objective lens (HCX PL APO CS; Leica) 
on an upright ﬂ  uorescence microscope (DMR2; Leica) ﬁ  tted with a camera 
(Orca; Hamamatsu). OpenLab 3.5.1 software (Improvision) was used for 
image acquisition. Live-cell imaging and FRAP analysis of GFP-PML IV in 
U-2 OS cells was performed as previously described (Dellaire et al., 2006). 
ImageJ v1.33 (National Institutes of Health) and Photoshop 7.0 (Adobe) 
software were used for image processing and analysis.
Statistical analysis
To determine mean PML NB number, maximum intensity projections of mul-
tiple focal planes were generated for the IF localization of PML using 
OpenLab 3.5.1 software (Improvision). PML NBs were counted in a mini-
mum of 30 cells per time point and the NB number per cell was normalized 
for nucleus size. Normalization of NB number was accomplished by multi-
plying the ratio of the area of each nucleus divided by the mean area of a 
nucleus in a given dataset. This calculation was necessary to account for 
the variability in PML NB number caused by cell cycle phase or ploidy 
(Dellaire et al., 2006). However, in normal diploid cell lines, this calcula-
tion will not affect the mean NB number per cell, but will reduce statistical 
variability between datasets. Each experiment was repeated in triplicate, 
and the mean PML NB number was used directly or divided by the mean 
number of bodies in the control (untreated) to give the fold induction of PML 
NBs. Error analysis for triplicate experiments is expressed as the SEM, 
where SEM = SD ÷ √3. For all other experiments, error analysis was 
  expressed simply as standard error. Datasets of PML NB number per cell 
exhibit a normal distribution; therefore, statistical signiﬁ  cance  between 
  datasets was derived using the t test for pair-wise analysis using Excel soft-
ware (Microsoft) and by ANOVA for testing the signiﬁ  cance of IR dose on 
PML NB number using online statistical tools available from http://www.
physics.csbsju.edu/stats/anova.html. Curve ﬁ  tting for PML NB induction 
versus dose of IR was accomplished online using tools available from 
http://zunzun.com.
Induction of subnuclear DNA damage by UV laser treatment
Cells grown on coverslips were incubated for 5 min in growth medium 
containing 0.5 μg/ml of Hoechst 333258 to sensitize cells to the UV 
  laser–induced damage. A confocal microscope (LSM 510; Carl Zeiss 
  MicroImaging, Inc.), equipped with an argon laser (488 nm) and tunable 
multiphoton laser (Chameleon; Coherent Inc.) capable of effective wave-
lengths in the UV range, was used to image cells and to generate UV 
  laser–induced damage using a 63×, 1.40 NA, oil-immersion objective 
lens (Plan-Apochromat; Carl Zeiss MicroImaging, Inc.). Laser damage was 
accomplished by selecting a region of interest (ROI) within a cell and 
bleaching the ROI using the tunable laser set at 790 nm (effective λ = 390 nm) 
and 20% power for a 200-ms pulse. At 20% power, the laser   generates 
7−8 mW, which translates to a cellular dose of  80 Gy (Bradshaw et al., 
2005). Images were collected immediately after the bleach, using the 
  argon laser at 50% power and 10% transmittance. Cells were maintained 
at 37°C during live-cell imaging, using a heated stage (Bioptechs).
Correlative LM/ESI
Samples were prepared and sectioned for correlative microscopy and 
ESI as previously described (Eskiw et al., 2003; Dellaire et al., 2004). 
  Nitrogen and phosphorus maps were collected using a transmission electron 
microscope (Tecnai 20; FEI) ﬁ  tted with an electron imaging spectrometer 
(Gatan). Immunogold labeling was accomplished using a secondary anti-
body conjugated to Ultrasmall nanogold (donkey anti–rabbit; Electron 
  Microscopy Sciences).
Online supplemental material
Fig. S1 shows the relative localization of PML NBs in respect to foci con-
taining γ-H2AX, Nbs1, and RPA over time, after etoposide induced DSBs. 
Fig. S2 shows the mathematical modeling of PML NB number in response 
to IR-induced DSBs and compares the number of DSBs induced by 20 μM 
etoposide versus varying doses of IR by neutral comet assay. Fig. S3 shows 
the biochemical composition of PML NBs over time after etoposide induced 
DSBs, in respect to SP100 and SUMO-1 content. Fig. S4 shows the effects 
of etoposide and caffeine, alone or in combination, on both the cell cycle 
proﬁ  le and PML NB number of NHDFs. Table S1 shows the ANOVA analy-
sis of PML NB number as a function of the dose of IR in NHDFs. Video 1 
shows the ﬁ  ssion of a PML microbody from a preexisting PML NB in re-
sponse to DSBs induced by etoposide. Video 2 shows the loss of positional 
stability of PML NBs after UV laser induction of DSBs. Video 3 shows a 
control cell where, in the absence of UV laser–induced DSBs, PML NBs are 
positionally stable. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200604009/DC1.
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